Diebold Nixdorf (DBD) Misses Q1 EPS by 13c; Reaffirms Outlook
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $84.16 +1.20%
EPS Growth %: +30.9%
Financial Fact:
Income (loss) from discontinued operations, net of tax: 500K
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: +30.9%
Financial Fact:
Income (loss) from discontinued operations, net of tax: 500K
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q1 EPS of ($0.12), $0.13 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.08 billion.
- Reaffirms 2018 non-GAAP outlook
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- ArcelorMittal (MT:NA) (MT) PT Raised to EUR65 at Jefferies
- JPMorgan Reinstates Dauch Corporation (DCH) at Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
